CVE-2025-47783

label-studio vulnerable to Cross-Site Scripting (Reflected) via the label_config parameter.

Description

Label Studio is a multi-type data labeling and annotation tool. A vulnerability in versions prior to 1.18.0 allows an attacker to inject a malicious script into the context of a web page, which can lead to data theft, session hijacking, unauthorized actions on behalf of the user, and other attacks. The vulnerability is reproducible when sending a properly formatted request to the `POST /projects/upload-example/` endpoint. In the source code, the vulnerability is located at `label_studio/projects/views.py`. Version 1.18.0 contains a patch for the issue.

Category

7.6
CVSS
Severity: High
CVSS 4.0 •
EPSS 0.06%
Affected: HumanSignal label-studio
Published at:
Updated at:

References

Link Tags
https://github.com/HumanSignal/label-studio/security/advisories/GHSA-8jhr-wpcm-hh4h

Frequently Asked Questions

What is the severity of CVE-2025-47783?
CVE-2025-47783 has been scored as a high severity vulnerability.
How to fix CVE-2025-47783?
To fix CVE-2025-47783, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-47783 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-47783 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-47783?
CVE-2025-47783 affects HumanSignal label-studio.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.